Table 4.

Markers of perycytes.

Marker	Clinical Trials	Pathological Issue	PMID
CD13+	Diffuse large B-cell lymphoma, primary central nervous system lymphoma, B cell lymphoma, solid tumors	Vascular permeability and CNS access of anticancer drugs, blood-brain barrier (BBB) penetration, diagnostic subtyping, cancer angiogenesis	32766857, 31118164, 30066366, 19900802
α-SMA	Colorectal cancer, nasopharyngeal carcinoma, chronic allograft nephropathy, usual interstitial pneumonia and nonspecific interstitial pneumonia	Metastasis and immune cell activity, neoangiogenesis, allograft injury (transplantation), fibrotic diseases	27248825, 24877105, 16236802, 15955241
NG-2	Neurologic and neurometabolic diseases	Replacement in neurologic diseases	24558163
RGS 5	Metastatic colorectal cancer	Tumor maturation	25069475
Desmin	Calcifying fibrous tumor, esophageal cancer, childhood sarcomas	Diagnosis, tumor progression and depth of invasion, diagnosis	31355265, 23801316, 1710539
DLK-1	Central precocious puberty, lung cancer	Timely diagnosis and treatment, prognostic factor	36577869, 33508526
Endosialin	Metastatic soft-tissue sarcomas, solid tumors, treatment-refractory solid tumors	Tumor angiogenesis, tumor shrinkage,	31034598, 30623276, 25398449